Loading…
Medtronic announced the planned acquisition of privately-held Companion Medical, manufacturer of the InPen smart insulin pen system, to expand its diabetes management portfolio.
“This acquisition is an ideal strategic fit for Medtronic as we further simplify diabetes management and improve outcomes by optimizing dosing decisions for the large number of people using multiple daily injection (MDI).”news.medtronic.com
Summarized from public sources; check the original articles before acting on it.